Updated July 2026 · 9 min read
Part of the ICU Emergencies Hub — browse every related guide in one place.
Disseminated intravascular coagulation is the disorder that seems to break the rules: the patient is clotting and bleeding at the same time. Tiny clots form throughout the microcirculation while the blood oozes from every line site and puncture. It is never a primary diagnosis — it is always the downstream signature of something else that is very wrong. The nurse who recognizes the pattern early buys time to fix the cause.
Some massive stimulus — sepsis, trauma, an obstetric catastrophe, a cancer, a severe transfusion reaction — dumps tissue factor and inflammatory signals into the bloodstream and switches on the clotting cascade everywhere at once. The result is uncontrolled thrombin generation and fibrin deposited throughout the small vessels. Those microclots consume platelets and clotting factors and shred red cells as they squeeze past (producing schistocytes on the smear). Then, having burned through the clotting machinery, the blood can no longer clot where it should — so the same patient who is throwing microthrombi starts to bleed from IV sites, the ET tube, the GI tract, and surgical wounds. Clotting and bleeding are not two problems; they are two faces of one runaway process.
No single test diagnoses DIC. It is a pattern of trends moving in a characteristic direction, read against a plausible trigger:
| Test | Direction in DIC | Why |
|---|---|---|
| Platelet count | Falling | Consumed by widespread clotting |
| D-dimer / FDPs | High and rising | Fibrin is being formed and broken down everywhere |
| Fibrinogen | Falling (may start high, then drop) | Consumed faster than the liver replaces it |
| PT / INR and aPTT | Prolonged | Clotting factors used up |
| Blood smear | Schistocytes | Red cells sheared by microclots |
The most specific single move is watching the trend: a platelet count and fibrinogen that are dropping hour over hour while the D-dimer climbs, in a patient sick enough to have a trigger, is DIC until proven otherwise. Scoring systems (such as the ISTH DIC score) formalize this by assigning points to the platelet count, the D-dimer, the fibrinogen, and the PT.
DIC does not have its own cure. It stops when the thing driving it stops. The nurse's most valuable contribution, beyond supporting the patient, is helping the team keep the trigger in focus:
This is the point that trips people up. In DIC, you do not transfuse to fix a lab value in a patient who is stable and not bleeding. Product is given to the patient who is actively bleeding, or who needs an invasive procedure, or whose numbers are dangerously low:
The worry that transfusing "adds fuel to the fire" of clotting is largely theoretical in the bleeding patient; the bleeding is the immediate threat and gets treated. Heparin is used only in selected DIC phenotypes where thrombosis dominates (for example, certain cancers), and that decision belongs to the team — it is never a reflex.
DIC is a surveillance diagnosis, and the bedside nurse often sees it before the labs are back:
A falling platelet count with organ injury is not automatically DIC. The thrombotic microangiopathies — TTP and HUS — also drop platelets and shear red cells, but in those disorders the PT, PTT, and fibrinogen are usually normal because the clotting cascade is not being consumed. That single distinction (normal coags in TTP vs. deranged coags in DIC) is one of the most useful at the bedside. See our companion guide on TTP. Likewise, heparin-induced thrombocytopenia drops the platelet count but drives clotting, not bleeding, and the coags are typically normal.
DIC is the body's clotting system running out of control and then running out of supplies — clotting and bleeding braided together. Recognize the pattern (oozing from everywhere plus falling platelets and fibrinogen, rising D-dimer, and prolonging coags), remember that the only cure is fixing the trigger, and give product to the patient who is bleeding or facing a procedure — not to a number on the screen. The nurse who notices the diffuse ooze and the drifting trend early is the one who gets the team looking for the sepsis, the abruption, or the malignancy that is actually driving it.
This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.